1) The document reviews evidence on the effectiveness of performance-based financing (PBF) and direct facility financing (DFF) approaches.
2) The Cochrane review found that PBF generally improved utilization and quality of targeted health services, but results were mixed for non-targeted indicators. Impacts on health outcomes were also mixed.
3) Evidence on DFF was limited but other reviews found prospective payment mechanisms like capitation can reduce costs while maintaining service utilization and quality of care.
Paying for performance to improve the delivery of health interventions in LMICsReBUILD for Resilience
This presentation from Sophie Witter & Karin Diaconu of Queen Margaret University, UK outlines the findings from a Cochrane review undertaken by the team on paying for performance to improve the delivery of health interventions in low and middle-income countries.
Presented by Ghassan Karem.
Part of a session - 'Context, gender, and sustainability in introducing and scaling-up essential health care packages in fragile and crisis-affected countries' - at the Fifth Global Symposium for Health Systems Research in October 2018. The essential package of health services is a mechanism for expanding equitable coverage of primary health care and essential hospital services in countries recovering from conflict. The session explored the evidence-base on such healthcare packages in different contexts and prioritized areas for strengthening research.
Health system strengthening evidence review – A summary of the 2021 updateReBUILD for Resilience
A presentation given by Professor Sophie Witter to the UK government's Foreign, Commonwealth & Development Office. This summarises a 2021 review of a health systems strengthening evidence review originally undertaken for the office in 2019.
Zimbabwe: Results-Based Financing Improves Coverage, Quality and Financial Pr...RBFHealth
A presentation by Dr. Gwinji, Permanent Secretary, Ministry of Health, Zimbabwe and Dr. Tafadzwa Goverwa- Sibanda, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014. This event was hosted by the Health Results Innovation Trust Fund at The World Bank, in partnership with the PBF Community of Practice in Africa.
This presentation was given at our launch meeting in Uganda which took place in July 2011. It provides an introduction to the research work we are planning in Northern Uganda.
A presentation by Bruno Meessen, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014.
Paying for performance to improve the delivery of health interventions in LMICsReBUILD for Resilience
This presentation from Sophie Witter & Karin Diaconu of Queen Margaret University, UK outlines the findings from a Cochrane review undertaken by the team on paying for performance to improve the delivery of health interventions in low and middle-income countries.
Presented by Ghassan Karem.
Part of a session - 'Context, gender, and sustainability in introducing and scaling-up essential health care packages in fragile and crisis-affected countries' - at the Fifth Global Symposium for Health Systems Research in October 2018. The essential package of health services is a mechanism for expanding equitable coverage of primary health care and essential hospital services in countries recovering from conflict. The session explored the evidence-base on such healthcare packages in different contexts and prioritized areas for strengthening research.
Health system strengthening evidence review – A summary of the 2021 updateReBUILD for Resilience
A presentation given by Professor Sophie Witter to the UK government's Foreign, Commonwealth & Development Office. This summarises a 2021 review of a health systems strengthening evidence review originally undertaken for the office in 2019.
Zimbabwe: Results-Based Financing Improves Coverage, Quality and Financial Pr...RBFHealth
A presentation by Dr. Gwinji, Permanent Secretary, Ministry of Health, Zimbabwe and Dr. Tafadzwa Goverwa- Sibanda, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014. This event was hosted by the Health Results Innovation Trust Fund at The World Bank, in partnership with the PBF Community of Practice in Africa.
This presentation was given at our launch meeting in Uganda which took place in July 2011. It provides an introduction to the research work we are planning in Northern Uganda.
A presentation by Bruno Meessen, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014.
The Science of Delivery: Use of Administrative Data in The HRITF PortfolioRBFHealth
A presentation by Ha Thi Hong Nguyen, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014. This event was hosted by the Health Results Innovation Trust Fund at The World Bank, in partnership with the PBF Community of Practice in Africa.
Innovations in Results-Based Financing in the Latin America and Caribbean RegionRBFHealth
Presentations delivered during "Innovations in Results-Based Financing in the Latin America and Caribbean Region" seminar at the World Bank on May 22, 2014.
These slides feature a comparative review of different types of results-based financing schemes in the Latin America and Caribbean region, as well as case studies from selected schemes.
Long run effects of temporary incentives on medical care productivity in Arge...RBFHealth
A presentation by Pablo Celhay, Paul Gertler, Paula Giovagnoli and Christel Vermeersch, delivered at the RBF Health Seminar, On the Road to Effective Universal Health Coverage: What’s New in Argentina’s Use of Performance Incentives? on June 11, 2015.
Presentation on the literature review of interventions to improve health care...IDS
This presentation was given in a Future Health System Consortium organised session at the Global Symposium on Health Systems Research in November 2010. The author is Alex Rowe from the Centers for Disease Control and Prevention.
The CMS Innovation Center held the fifth in a series of webinars for potential applicants interested in applying to Health Care Innovation Awards Round Two. The webinar held on Wednesday, June 26, 2013 from 1:00–2:00pm EDT, focused on measuring project success and developing an operational plan.
- - -
CMS Innovations
http://innovations.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Analysis of cross-country changes in health services IDS
This presentation was given in a session at the Global Symposium on Health Systems Research which was organised by the Future Health Systems Consortium. The author is Toru Matsubayashi from Johns Hopkins Bloomberg School of Public Health
Presentation from Professor Sophie Witter at the Institute of Development Studies' learning session 'Health financing priorities in the time of Covid-19?'
Data Governance for Real-World Evidence: Cross-country differences and recommendations for a governance framework
Cole, A., Garrison, L., Mestre-Ferrandiz, J. & Towse A.
In this July 11, 2012 webinar, CMS Innovation Center staff discussed the amended Funding Opportunity Announcement (FOA) for the Strong Start for Mothers and Newborns initiative.
More at: http://www.innovations.cms.gov/resources/StrongStart_FOA.html
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
The CMS Innovation Center hosted an informational webinar March 11, 2014 on the parameters of Models 2-4 of the Bundled Payments for Care Improvement Initiative. This webinar was geared towards physicians, specialty practices and physician group practices.
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Verification in Results-Based Financing for Health: Summary of Findings and R...Erik Josephson
This is the executive summary to the forthcoming report looking at verification in six RBF mechanisms in Afghanistan, Argentina, Burundi, Panama, Rwanda and the UK.
The Science of Delivery: Use of Administrative Data in The HRITF PortfolioRBFHealth
A presentation by Ha Thi Hong Nguyen, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014. This event was hosted by the Health Results Innovation Trust Fund at The World Bank, in partnership with the PBF Community of Practice in Africa.
Innovations in Results-Based Financing in the Latin America and Caribbean RegionRBFHealth
Presentations delivered during "Innovations in Results-Based Financing in the Latin America and Caribbean Region" seminar at the World Bank on May 22, 2014.
These slides feature a comparative review of different types of results-based financing schemes in the Latin America and Caribbean region, as well as case studies from selected schemes.
Long run effects of temporary incentives on medical care productivity in Arge...RBFHealth
A presentation by Pablo Celhay, Paul Gertler, Paula Giovagnoli and Christel Vermeersch, delivered at the RBF Health Seminar, On the Road to Effective Universal Health Coverage: What’s New in Argentina’s Use of Performance Incentives? on June 11, 2015.
Presentation on the literature review of interventions to improve health care...IDS
This presentation was given in a Future Health System Consortium organised session at the Global Symposium on Health Systems Research in November 2010. The author is Alex Rowe from the Centers for Disease Control and Prevention.
The CMS Innovation Center held the fifth in a series of webinars for potential applicants interested in applying to Health Care Innovation Awards Round Two. The webinar held on Wednesday, June 26, 2013 from 1:00–2:00pm EDT, focused on measuring project success and developing an operational plan.
- - -
CMS Innovations
http://innovations.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Analysis of cross-country changes in health services IDS
This presentation was given in a session at the Global Symposium on Health Systems Research which was organised by the Future Health Systems Consortium. The author is Toru Matsubayashi from Johns Hopkins Bloomberg School of Public Health
Presentation from Professor Sophie Witter at the Institute of Development Studies' learning session 'Health financing priorities in the time of Covid-19?'
Data Governance for Real-World Evidence: Cross-country differences and recommendations for a governance framework
Cole, A., Garrison, L., Mestre-Ferrandiz, J. & Towse A.
In this July 11, 2012 webinar, CMS Innovation Center staff discussed the amended Funding Opportunity Announcement (FOA) for the Strong Start for Mothers and Newborns initiative.
More at: http://www.innovations.cms.gov/resources/StrongStart_FOA.html
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
The CMS Innovation Center hosted an informational webinar March 11, 2014 on the parameters of Models 2-4 of the Bundled Payments for Care Improvement Initiative. This webinar was geared towards physicians, specialty practices and physician group practices.
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Verification in Results-Based Financing for Health: Summary of Findings and R...Erik Josephson
This is the executive summary to the forthcoming report looking at verification in six RBF mechanisms in Afghanistan, Argentina, Burundi, Panama, Rwanda and the UK.
International Food Policy Research Institute (IFPRI) organized a three days Training Workshop on ‘Monitoring and Evaluation Methods’ on 10-12 March 2014 in New Delhi, India. The workshop is part of an IFAD grant to IFPRI to partner in the Monitoring and Evaluation component of the ongoing projects in the region. The three day workshop is intended to be a collaborative affair between project directors, M & E leaders and M & E experts. As part of the workshop, detailed interaction will take place on the evaluation routines involving sampling, questionnaire development, data collection and management techniques and production of an evaluation report. The workshop is designed to better understand the M & E needs of various projects that are at different stages of implementation. Both the generic issues involved in M & E programs as well as project specific needs will be addressed in the workshop. The objective of the workshop is to come up with a work plan for M & E domains in the IFAD projects and determine the possibilities of collaboration between IFPRI and project leaders.
Four strategies to upgrade clinical trial quality in this computerized world ...Pubrica
• Biostatistics Services is important for collecting, reviewing, presenting, and interpreting data in clinical research.
• Applications of clinical biostatistics services are in different areas, such as epidemiology, clinical trials, population genetics, the biology of structures, and more.
Reference : https://pubrica.com/services/research-services/biostatistics-and-statistical-programming-services/
Continue Reading: http://bit.ly/36nwtcs
Why Pubrica?
When you order our services, Plagiarism free|onTime|outstanding customer support|Unlimited Revisions support|High-quality Subject Matter Experts.
Contact us :
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom: +44- 74248 10299
Impact of Performance-Based Financing (PBF) and On Maternal and Child Health ...IIJSRJournal
The purpose of this study is to investigate the impact of performance-based financing (PBF) on maternal and child health in Nigeria. PBF is proposed as a holistic reform approach that aims to improve the aforementioned shortcomings among others in healthcare provision. In Nigeria, this unique funding approach based on performance was piloted in 2011 with Adamawa, Nasarawa and ONDO states and later additional five States are Borno, Yobe, Gombe, Taraba and Bauchi which were added in 2016. It is expected that if these States demonstrates effectiveness in yielding the expected health outcomes especially as it pertains to the attainment of the stated health-related SDGs, the project would be implemented in all the States of the federation. This necessitates the need for an objective assessment of the impact of Performance-Based Financing especially as it pertains to maternal and child health. Against this background, data on key health indicators like number of ANC visits, Completely Vaccinated Children (CVC), Out Patient Department (OPD) attendance, Deliveries at the health centre and the number of Family Planning Services Uptake were collected at the Primary health care centre level in three States-Adamawa, Nassarawa and ONDO States. The Ex post facto and causal research design was used for the study. A sample size of one hundred and sixty two (162) primary health care facilities will be selected for the study representing approximately 20% of the study population which is adequate. This selection was done using a multi-stage sampling technique. Data collected was analyzed using basic descriptive statistics and the General Linear Model (GLM) approach involving the Two-way Mixed effects ANOVA Statistic. It was found that at 0.05 significant levels PBF health facilities perform better than the conventionally funded health facilities in terms of number of ANC visits, OPD attendance, deliveries at the health centres, CVCs and the number of family planning services. Consequently, it was concluded that PBF has had a significant impact on the health care quality of Primary Health Care Centres in the Piloted States. As a result it is recommended that the PBF program should be scaled up to all the States of the Federation and also the need to incorporate the PBF tenets in to the new Basic Health Care Provision Funds, BHCPF, among others were recommended.
Performance-based financing of maternal and child health: non-experimental ev...RBFHealth
Ellen Van de Poel presents the findings of two studies that evaluate the impact of Performance-Based Financing (PBF) in Burundi and Cambodia. Both studies exploit the geographic expansion of PBF to estimate its effect on the utilization of maternal and child health services using data from the Demographic Health Surveys.
A presentation entitled 'Exploratory review of financial autonomy at primary care level', given by Professor Sophie Witter at the 6th Meeting of the Montreux Collaborative Conference
Presentation given by Sophie Witter & Christabel Abewe at the 2023 IHEA conference. It was entitled 'Financial protection in Uganda: Reflections from an HFPM assessment'
A presentation given at HSR2022 by Professor Sophie Witter. It looks at:
* What is the evidence on the role of governance for health system strengthening?
* What are the particular challenges for FCAS health systems?
* What is our state of knowledge on governance specifically?
* What are the priorities in relation to governance of the private sector in FCAS?
Presentation given by Professor Sophie Witter at the 5th Meeting of the Montreux Collaborative on Fiscal Space, Public Financial Management and Health Financing in November 2021
The comparative agility of the community health worker cadre in fragile & con...ReBUILD for Resilience
In this presentation Joanna Raven explores the comparative agility of the community health worker cadres in four fragile & conflict-affected contexts - Lebanon, Myanmar, Nepal and Sierra Leone.
Health system strengthening – what is it, how should we assess it, and does i...ReBUILD for Resilience
This presentation was given to the UK's Department for International Development on 30th July 2019.
Comprehensive reviews of health system strengthening interventions are rare, partly because of lack of clarity on definitions of the term but also the potentially huge scale of the evidence. In our talk, we will reflect on the process of undertaking such an evidence review for DFID recently (attached again), drawing out suggestions on definitions of HSS and approaches to assessment, as well as summarising some key conclusions from the current evidence base. Most HSS interventions have theories of change relating to specific system blocks, but more work is needed on capturing their spill-over effects and their contribution to meeting over-arching health system process goals. We will make some initial suggestions about such goals, to reflect the features that characterise a ‘strong health system’. We will highlight current findings on ‘what works’ but also that these are just indicative, given the limitations and biases in what has been studied and how, and argue that there is need to re-think evaluation methods for HSS beyond finite interventions and narrow outcomes. Clearer concepts, frameworks and methods can support more coherent HSS investment.
Understanding Iraq’s BHSP: Examining the Domestic and External Politics of Po...ReBUILD for Resilience
Presented by Goran Abdulla Sabir Zangana, Health Policy Research Organisation, Iraq.
Part of a session - 'Context, gender, and sustainability in introducing and scaling-up essential health care packages in fragile and crisis-affected countries' - at the Fifth Global Symposium for Health Systems Research in October 2018. The essential package of health services is a mechanism for expanding equitable coverage of primary health care and essential hospital services in countries recovering from conflict. The session explored the evidence-base on such healthcare packages in different contexts and prioritized areas for strengthening research.
Context, gender and sustainability in introducing and scaling-up essential he...ReBUILD for Resilience
Presented by Egbert Sondorp of KIT Royal Tropical Institute, Netherlands.
Part of a session - 'Context, gender and sustainability in introducing and scaling-up essential health care packages in fragile and crisis-affected countries' - at the Fifth Global Symposium for Health Systems Research in October 2018. The essential package of health services is a mechanism for expanding equitable coverage of primary health care and essential hospital services in countries recovering from conflict. The session explored the evidence-base on such healthcare packages in different contexts and prioritized areas for strengthening research.
Gender and Essential Packages of Health Services: Exploring the Evidence BaseReBUILD for Resilience
Presented by Val Percival of Norman Paterson School of International Affairs, Carleton University, Canada.
Part of a session - 'Context, gender, and sustainability in introducing and scaling-up essential health care packages in fragile and crisis-affected countries' - at the Fifth Global Symposium for Health Systems Research in October 2018. The essential package of health services is a mechanism for expanding equitable coverage of primary health care and essential hospital services in countries recovering from conflict. The session explores the evidence-base on such healthcare packages in different contexts and prioritizes areas for strengthening research.
The changing health care needs of communities and health systems responses in...ReBUILD for Resilience
Presentation given by Tim Martineau as part of a Satellite Session at the Fifth Global Symposium on Health Systems Research on 9th October 2018: 'No longer invisible - finally bridging the divide between health care, social and societal engagement to build systems for health', organised by CORE Group and Save the Children.
The changing health care needs of communities and health system responses in ...ReBUILD for Resilience
Presentation given by Tim Martineau of Liverpool School of Tropical Medicine, UK and the ReBUILD Consortium on health systems in fragile settings and their changing needs.
Presented as part of a session at the Fifth Global Symposium for Health Systems Research - 'No Longer Invisible - finally bridging health care, social and societal engagement to build systems for health' in October 2018.
Performance based financing as a way to build strategic purchasing in fragile...ReBUILD for Resilience
Presentation given by Sophie Witter at a Satellite Session on "Payment for Performance, how, why, where and what?", at the Fifth Global Symposium on Health Systems Research in Liverpool, on 9th October 2018.
Etat des connaissances sur le renforcement des systèmes de santé dans les con...ReBUILD for Resilience
Presentation (French language) on the state of knowledge on health systems in fragile contexts, given by Professor Sophie WItter at an International Workshop at the Institute of Tropical Medicine in Antwerp on 16th October 2018.
Investigating results based financing as a tool for strategic purchasing _ Co...ReBUILD for Resilience
Presentation given by Maria Paula Bertone at a Satellite session of the 5th Global Symposium on Health Systems Reseach, on "Payment for Performance, how, why, where and what? Learning from research across income settings. Tuesday 9th October 2018.
Health financing in fragile and conflict affected settings - Insights from pr...ReBUILD for Resilience
Presentation given by Professor Sophie Witter at a Satellite session of the 5th Global Symposium on Health Systems Reseach, on "Health financing in fragile an conflict-affected states: controversies and innovations" on Monday 8th October iin Liverpool, UK.
Presentation given by Sophie Witter at a satellite session on "Health financing in fragile & conflict affected settings - controversies and innovations" at the 5th Global Symposium on Health Systems Research in Liverpool, on 8th October 2018.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Performance-based financing presentation to the Health Financing Accelerator
1. Review of Global Fund experience with
facility-level financing: some insights for
health financing Accelerator
SOPHIE WITTER, MARIA BERTONE & KARIN DIACONU
2ND MARCH 2021
2. Overview
1. Framing and core concepts
2. Present a summary of the overall literature on their effectiveness
3. Reflections on selected GF experiences with PBF
4. Lessons arising for the Global Fund and other global actors
5. Q&A
4. Core concepts
Focus on front-line funding (so not whole range of RBF/PfR instruments)
PBF vs DFF
◦ DFF less clearly designed but generally seen as prospective payment which bypasses middle levels of health system;
budgets can be set in different ways
Both driven largely by shared failure to adequately finance primary care in many LMIC settings
◦ This failure reflects a combination of resource shortage, political economy (favouring higher level facilities), system
failures (weak PFM) but also low levels of trust
◦ PBF incorporates more of a focus on lack of effort by facilities/staff – hence incentives + measurement
◦ DFF emphasises resource shortages more – can’t be accountable without funds
◦ Whether it is best to address these through PBF, DFF or reforms to basic PFM systems will depend on the context
Neither PBF nor DFF are new, and they have had many earlier forms with different labels
Seen as alternatives but could also be complementary
Share many prerequisites for effectiveness in terms of health systems
7. Methods
Report and presentation outline available evidence on PBF and DFF and their effectiveness
Literature on PBF draws primarily on:
◦ Cochrane review – conducted by study authors over 2017-2020, in public domain soon
◦ Comment on similarities with World Bank meta-analysis
Literature on DFF draws on a rapid review of the evidence
◦ Non-systematic search using combination terms ‘facility’ or ‘clinic’ with ‘finance’ and/or ‘direct’;
◦ Drawing on available reviews –e.g. on prospective financing mechanisms;
◦ Reviewing documentation submitted by GF.
9. Main source of evidence: Cochrane review (1)
Cochrane review included 59 studies which assessed effects of PBF
Nr. studies 1 2 4-5 6-10
Figure 1: Number of PBF impact evaluations by
country (as included in review)
• Majority from Rwanda, China and
Tanzania
• Schemes predominantly focusing on
reproductive maternal and child care,
but some on TB/HIV specifically
• Usually P4P implemented in
public/faith based facilities
• Majority of schemes funded by
national governments, but similar
numbers supported by external
agencies (WB among others)
10. Cochrane review: Types of studies included
24 %
(14) RCT
27%
(16)
non-RCT
32%
(19) CBA
15% (9)
ITS
10
RCT = randomized controlled trial;
CBA = controlled before and after study;
ITS = interrupted time series;
1 study additionally both ITS + CBA
42 studies reporting effects against standard care or status
quo, no change
13 report effects against an enhanced financing control /
other financing modality or alternative
4 report against both standard care and enhanced financing
On average, studies report effects of the P4P scheme at 3
years, but this varies widely (from 1-17 years in cases)
11. Cochrane review: grouping evidence to determine
effects
Comparison
Standard care or
status quo control
Other intervention -
usually matched
financing
Indicator targeted?
Targeted
Not-targeted
Targeted
Not-targeted
Sufficient data
available?
Indicator for
comparison must be
similarly defined and
assessed in 2 or
more studies
Summarise range of effect
(usually % change
attributed to P4P) by
indicator
T1: BCG Immunization
NT1: BCG Immunization
T2: Institutional deliveries
NT2: Institutional deliveries
T1: BCG Immunization
NT1: BCG Immunization
T2: Institutional deliveries
NT2: Institutional deliveries
Summarise by clinical
areas
Summarise by review
outcome
Child immunization
RMNCH: deliveries
Child immunization
RMNCH: deliveries
Child immunization
RMNCH: deliveries
Child immunization
RMNCH: deliveries
Against control:
Targeted measures of
service delivery
Against control:
Untargeted measures
of service delivery
Against comparator:
Targeted measures of
service delivery
Against comparator:
Untargeted measures
of service delivery
We do not produce meta-estimates, instead indicating range of effect and judgment on overarching direction of effects
Is P4P yielding desirable, neutral, undesirable or uncertain effects?
12. Indicate range of effect and judgment for each outcome on whether effects of the intervention
are:
◦ Desirable: consistently positive and over 5%
◦ Neutral: under 5%
◦ Undesirable: consistently negative and over 5%
◦ Uncertain: where either the quality of the evidence or the effects themselves are too varied to
judge
5% threshold is contextualized – i.e. for health outcomes we do not adopt this, but for other
measures (e.g. utilization) we do
12
Cochrane review: Classification of effects
13. PBF can take many forms (1): Scheme classification
Scheme classification Details on scheme Countries (n) Study types (n) Comparators (n)
Capitation and PBF Payment reforms including capitation
and PBF elements
China (2) RCT (1) and quasi-
non randomized trial
(1)
Fee for service (1) and global capitated budget
only (1)
Conditional provision of
material goods
Conditional provision of material
goods alongside supervision and
quality improvement strategies
Tanzania (1) Quasi-non
randomized trial (1)
Unconditional gifts (either immediate or
delayed) as alternative interventions and control
(all receive a standard encouragement
intervention) (1)
Financial and non-
financial incentives +
clinical decision guide
Mix of financial and non-financial
incentives, alongside clinical decision
guide and supervision/technical
support
Burkina
Faso, Ghana and
Tanzania (all in 1)
CBA (1) Control as standard care (1)
Performance related pay Performance-related pay (results-
based management) involving
different types of agreement
according to province implemented
(ranging from multi-level agreements
with strategic targets to not specified)
Brazil (1) ITS (1) Comparison of impact over time in
implementing provinces. (1)
Performance based
contracting or service
agreements
Service agreements introduced as part
of reform and in case of contracting,
with indicators for performance
chosen at year end to avoid distortion
Cambodia (2),
Haiti (1)
CBA (2), ITS (1) Routine practice as control (2) and comparison
of indicators over time. (1)
Hybrid scheme Payment per output and for target China (1), Peru
(1)
Quasi/non
randomized trials (2)
Control as standard care (2)
Results based aid Fixed element alongside a targeted
element as part of results based aid
El-Salvador (1) CBA (1) Control as status quo (1)
13
14. Scheme classification Details on scheme N. Countries included (n) Study types (n) Comparators (n)
Payment per output Payment for each output 9 Afghanistan (1), Argentina
(1), China (1), Cambodia (2),
DRC (1), Swaziland (1),
Rwanda (2)
RCT (4), Quasi/non-
randomized (2), ITS
(2), CBA (1)
Control as status quo/standard care (4),
comparison over time in implementing
locations (2), comparator of matched funding
or background PBF programmes into which
experiments nested (3)
Payment per output with
income potentially withheld
1 China (1) ITS (1) Comparison of impact over time in
implementing hospital. (1)
Payment per output including
revenue
1 China (1) ITS (1) Comparison over time in implementing
provinces (1)
Payment per output
modified by quality
score
Payment per output with
quality as multiplicative
adjuster (between 0-1)
11 Congo (1), Zambia
(1), Benin (1), Rwanda (8)
Quasi/non-
randomized trial (8),
CBA (1), ITS (2)
Control with standard care (2), Over time
comparison in implementation areas (2),
Comparator of matched funding (7)
Payment per output with
quality bonuses (quality
adjuster an additional but not
detracting component)
7 Burundi (4), Zambia (2) RCT (2) and CBA (4) Control as standard care (5), Comparator of
enhanced matched financing (2)
No description of payment
equation - quality adjustment
noted
1 Afghanistan (1) RCT (1) Control with standard care (1)
Payment per output
modified by quality
and equity score
Modification to payment
equation based on population
equity or remoteness of
facilities
5 Burkina Faso (1), Cameroon
(2), DRC (1), Zimbabwe (1)
Quasi/non
randomized trials
(2), CBA (3)
Control as standard care (4) and comparator
including equipment and other in kind
support (1)
Payment per output
modified by quality
and satisfaction score
Modification to payment
including bonuses for
enhanced patient satisfaction
2 Malawi (1), Zimbabwe (1) CBA (2) and ITS (1)
(one study does
both)
Control as standard care (2)
PBF can take many forms (2): majority of schemes are payment per output
14
15. Details on scheme N. Countries included (n) Study types (n) Comparators (n)
Potential for income gain only 12 Argentina (1), Kenya (1), Philippines
(4), Tanzania (4)
RCT (5), CBA (5) Control as standard care/status quo
(12)
Potential for income withheld 1 China (1) ITS (1) Over time (1)
Target payment or payment per
input
1 India (1) RCT (1) Control as status quo (1)
PBF can take many forms (3): Target payment
15
How do scheme effects compare?
• Performance based contracting and results based aid seem to achieve best outcome effects, but minimally assessed.
• Overall, schemes adjusting for quality + equity perform best against utilization outcomes (payment per output
schemes performed best, but target payment + adjustments also).
16. Overview of results against standard care (1)
Outcome Summary of impacts GRADE
Utilization and
delivery of health
services
Overall inconsistent picture: the intervention may improve some utilization and delivery
indicators but may lead to poorer results for other indicators.
When targeted:
Proportion of persons receiving HIV testing (range 6-600%) and delivery of PMTCT (range
3.8 to 21%) may be affected positively; proportion of persons receiving ART and children
(up to 120% decline) and households protected with bednets may decline (up to 7.3%);
effects on tuberculosis adherence are uncertain given very low certainty evidence;
effects on family planning outreach may be positive (moderate certainty evidence,
increase up to 300%)
Evidence on mother and child immunizations and antenatal care utilization is mixed.
Effects on indicators when they are not targeted are largely uncertain or neutral.
⊕⊕⊖⊖
Low
16
17. Overview of results against standard care (2)
Outcome Summary of impacts GRADE
Quality of care
(mainly assessed by
score)
Largely uncertain overall.
Effects on quality of care indicators appear to be sustained only when indicators are targeted.
Indicators for which moderate certainty evidence was found include:
P4P probably improves quality of care scores (range 5 to 300% relative increases);
P4P probably improves the quality scores of available medicine and equipment, effects
ranged from 2.7% to 220%;
Overall quality of service by specific departmental area/service: P4P probably improves
the average quality of service scores in specific targeted areas (effects ranged from 39%
to 15-fold increase in scores).
P4P may make little or no difference to staff knowledge and skills (low certainty evidence).
⊕⊕⊖⊖
Low
17
18. Overview of results against standard care (3)
Outcome Summary of impacts GRADE
Health outcomes When targeted:
P4P may reduce child mortality / 1000 children born alive (range: relative change
0.2-6.5%);
P4P may lead to a modest reduction of 2-3% in the proportion of children with
reported anaemia;
P4P may increase the likelihood of tuberculosis treatment success (range: 12-20%
improvement in treatment success).
Evidence on neonatal mortality is inconsistent: P4P may have desirable effects
and ensure reduction in neonatal mortality in implementing clinics by up to 22%
in one study, however, another study identified increases in region of 6.5% across
catchment areas of P4P incentivized providers.
⊕⊕⊖⊖ Low
Unintended effects No distorting unintended effects. ⊕⊕⊖⊖ Low
18
19. Overview of results against standard care (4)
Outcome Summary of impacts GRADE
Changes in resource
use
Overall certainty in evidence across indicators is low, for those where moderate
certainty observed:
P4P probably has a positive effect on human resource availability (range for
relative change compared to contorl: 19-44%, moderate certainty evidence).
P4P probably affects infrastructure functionality and medicine availability
positively.
⊕⊕⊖⊖ Low
19
20. Overview of results against standard care (5)
Outcome Summary of impacts GRADE
Provider motivation,
satisfaction,
absenteeism and
acceptability
P4P probably makes little or no difference to provider absenteeism (range: 0.7-
2%, low certainty evidence). Effects on overall motivation scores and
satisfaction are largely neutral (low certainty evidence).
Where these outcomes were not directly targeted, the intervention may have
desirable effects.
⊕⊕⊖⊖
Low
Patient satisfaction and
acceptability
• Overall positive, with only two outcomes noting limited to no effect in
relation to the intervention (satisfaction with care quality and provider
communication).
• When not targeted, effects may be largely positive, except for satisfaction
with provider-patient contact time and facility opening hours.
⊕⊕⊖⊖
Low
20
21. Overview of results against standard care (6)
Outcome Summary of impacts GRADE
Impacts on
management or
information systems (if
not a targeted measure
of performance)
P4P may positively affect facility managerial autonomy (low certainty evidence),
probably makes little to no difference to management quality or facility
governance.
⊕⊕⊖⊖
Low
Equity considerations:
evidence of differential
impacts on different
parts of the population
• P4P may increase the proportion of poor persons utilizing child
immunization services, however the intervention may potentially decrease
the proportion of poor persons utilizing antenatal care.
• P4P may make little to no difference to the utilization of institutional
deliveries by poorest groups.
• If not explicitly targeted, effects are mixed.
⊕⊕⊖⊖
Low
21
22. Comparison to WB meta-analysis
Not yet in public domain, so based on presentation summarising results
Overall results of reviews are consistent, but the aggregation of indicators in WB meta-analysis different
than Cochrane (bear in mind when reading both!)
PBF has a positive mean impact on utilization of modern contraceptives, however CCTs may outperform
PBF designs for this.
ANC: PBF impacts on women accessing 4 or more visits are variable and likely indicative of little to no
important effect (ranging from -3% to 2%), however PBF programs appear associated with higher
likelihood of women receiving tetanus vaccinations as part of ANC.
Institutional deliveries: PBF may perform better than voucher and CCT programs
24. Review on prospective payment mechanisms
Reviews capitation, global budgets and DRG, and their effects on health expenditure, service
utilization and care quality
Concludes that such mechanisms can effectively reduce administrative and health system
expenditure on health, as well as lower demand-side expenditure.
Mixed designs – where facilities implement a mixed capitated budget and PBF intervention – are
noted to be particularly effective
25. DFF schemes reviewed: context
Context element Tanzania Kenya Papua New Guinea
Policy and service
landscape
User fees routinely charged
Decentralization desired - fiscal,
administrative and for decision-
making to ensure responsiveness to
population needs
User fees routinely charged
Challenges with ensuring service
equity, particularly for rural facilities
User fees routinely charged
Low level of per capita spend
More responsiveness to population
Problem areas to
be tackled by DFF
Poor quality of care at facility level,
high user fees, delayed transfers of
funds from districts to facility
Poor quality of care, infrastructure,
supply of medications and low staff
morale at facility level;
delayed transfers of funds from
districts to facility and retention of
high % at district
High service coordination costs at
district; Limited funding trickling
down to facility; Facility ownership
of service delivery currently
undermined by excessive district
and central management
Scale of
implementation
Pilot in Bukoba and then expanded
to 7 regions
Pilot in Coast Province, 7 district
One province: Bougainville, then
expanded to national as part of
reform
Time period Started 2017/18 2005-2007 and further scaled
Pilot start unclear, but 2014 onward
for national implementation
Funder Health Basket Fund (Joint donor) DANIDA and Ministry of Health AUSAID NZAID
26. DFF schemes reviewed: design
Facility teams
prepare budgets
(and workplans)
yearly and
quarterly
Review of these
at district or
province levels
Funds are
disbursed
(quarterly
usually) and
used
Reporting of
expenditure but
not verification
Elaborate the overall
budget that can be used +
put in place, mechanisms
for disbursal of funds (bank
accounts), reporting and
support (e.g. accountants at
district level) and
27. DFF schemes reviewed: design and mechanism
Design and
mechanism Tanzania Kenya Papua New Guinea
Actors
DHMT and County Health Management Team
conduct supportive supervision and mentorship,
review fidelity of implementation
(respectively);Facility teams and governance
committee; financial assistants at district level
Provincial health management
team oversees province and has
support of provincial
accountant; same structure
replicated at district; Facility
Management Nurse works
specifically on community
outreach and strengthening
planning capacity of health
facility committees; health
facility committees
Health facility committees main
ones to approve plans, budgets
and reports (no allowances
given); Province CEO and
accountants to monitor scheme
and ensure accountability –
have the option to withhold
funds if needed
Capacity
building
For reporting and budgeting and community
mobilization
For reporting, budgeting, and
community engagement
For budget preparation and
auditing
Supervision
Enhanced mentorship and supervision as
previous
As per routine + for accounting As per routine + for accounting
Accountability
Enhanced community involvement in planning,
enhanced reporting
Health facility committees and
financial reporting enhanced;
blackboards showcase
expenditure to community
Enhanced mechanisms for
auditing, including increased
meeting frequency for facility
committees
28. DFF schemes reviewed: impacts
Tanzania Kenya Papua New Guinea
Evaluations are ongoing –
available evidence is positive
and suggests similar impacts as
in Kenya
• No reduction in relation to
user fees
• Improvements in the working
environment
• Predictability of staff being
funded increased and more
staff attendance
• Increased utilization of
services and patient
satisfaction + perceptions of
care quality increase too
• Limited impact on user fees
• Increases in utilization, but
unclear if attributable to the
DFF scheme
29. Section 2:
How do PBF and DFF
effects compare?
EVALUATIONS TO DATE OF A ‘DFF LIGHT’ MODEL
30. Evaluations comparing the two designs
Country Evaluation reference PBF design DFF design
Benin Lagarde 2015; de
Walque et al. Endline
report
Payment per output modified by quality score
(quality score index with 124 quality criteria
bounded between 0-1)
Matched financing equivalent to PBF
(adjusting for core indicators as per PBF) and
similar managerial autonomy as for PBF.
Cameroon de Walque 2017 Payment per output modified by quality and
equity considerations (bonus, but if
verification identified discrepancies, potential
for income withheld). Limited managerial
autonomy.
Matched financing equivalent to PBF (on
monthly basis) and managerial autonomy to
use funds facility as desired (including staff
hire)
DRC Huillery 2017 Payment per output. Matched financing equivalent to PBF,
calculated based on number of health care
workers available.
Nigeria Kandpal 2018 Payment per output modified by quality and
equity considerations (bonus)
Facilities receive half of funds that PBF
facilities receive, and there is autonomy to
spend as desired (no allowance to pay staff).
Zambia Friedman 2016 Payment per output modified by quality and
equity score
Matched financing equivalent to PBF and
additional equipment (same as the PBF).
31. Which one is preferable? (1)
Country Health service utilization and delivery Quality of care
Benin At midline, DFF desirable: Consultations logged per staff in PBF group
lower than in DFF. At endlne (2017), DFF and PBF perform relatively
similarly, there are no statistical differences, but DFF still assures higher
utilization for postnatal utilization, family planning utilization and malaria
cases treated in under 5s.
At midline: Process quality of care across diverse RMNCH areas increases,
but equipment quality decreases in comparison to DFF; PBF facilities had
overall 10.1% more financial resources than comparator.
Cameroon DFF group sees 2 additional deliveries/month, similar effects observed on
ANC quality. For immunizations, family planning, HIV testing, PBF group
outperforms DFF, but no important effects on PTMCT or ART delivery.
Equipment availability higher in the DFF groups, but no important effects
and differences on vaccine availability or medication availability. Family
planning supplies predominantly available in PBF facilities, no important
effects on malaria treatment.
DRC DFF desirable: limited effects on likelihood of having BCG vaccination,
reduction in postnatal care utilization and other items.
PBF effects on process quality compared to DFF are mixed, but overall 8%
reduction in correct medical prescriptions, increases in length of stay
following delivery and overarching quality score is lower. Equipment
availability is also relatively lower, though infrastructure functionality
higher compared to DFF.
Nigeria "Of the 8 quantity indicators included in the IE, DFF achieved larger
adjusted DiDs on 4, however, PBF achieved statistically greater
improvements in skilled birth attendance and the related institutional
delivery rate. PBF may have also done better on modern contraceptive
prevalence rate but DFF likely achieved better results on immunization
and ITN use."
Evaluation notes similar impacts.
Zambia Immunization service delivery and utilization 40% higher in PBF groups,
increases of 8% in curative visits in over 5 year olds, but decrease in under
5. Generally neutral impacts on ANC in comparison to DFF but negative
effects relative to DFF for family planning utilization.
PBF likely desirable: Slight positive effects on procedural care quality in
general, except for family planning where effects are 40% higher
compared to DFF; 75% more equipment available, however significantly
less medicines available (relative effect -160%).
Inconclusive DFF preferable PBF preferable
32. Which one is preferable? (2)
Country Health outcomes Facility autonomy
Benin Not assessed. Similar across groups and difficult to distinguish,
initial design emphasised this element across both
arms.
Cameroon Not assessed. By design similar.
DRC DFF desirable: PBF facilities have slight increased
likelihood of child mortality and reductions in height
and weight scores for under 5s observed.
Not assessed quantitatively.
Nigeria Not assessed. Not assessed quantitatively.
Zambia PBF desirable: 10.5% reduction in sickness in under
5s.
PBF desirable: autonomy scores are 46% higher in
PBF facilities compared to DFF.
Inconclusive DFF preferable PBF preferable
34. Methods
We carried out four case studies to accompany the main report on PBF/DFF:
◦ PBF programmes which were co-funded by the GF
◦ Present the overall context, design and implementation (including challenges and outcomes) of PBF
◦ Focus also on the GF’s perspective – what was the set up and the specific challenges related to the GF’s
contribution
◦ DFF is not considered (in some of these setting DFF-like interventions were included as ‘control’ for a
PBF IE, but not all were funded by the GF)
Cases selected: Benin, DRC, Cote d’Ivoire and Haiti
◦ Note that all are rapid case studies, and in particular the last two
35. Focus
In this presentation, after an overview of the PBF programmes, we focus on the
following specific themes/issues:
1. The GF’s perspective – GF’s involvement in PBF, partnership structures, challenges and
lessons learnt
2. PBF integration and sustainability
3. PBF as a donor coordinating mechanism
36. Benin DRC Cote d’Ivoire Haiti
History of the project
Period of
implementation
2012 – 2017 2014 - ongoing 2015 - ongoing 2013 - ongoing
Coverage 2012-2015: 8 out of 34 districts in the
country (WB)
2015-2017: additional 19 districts (GF),
3 districts (GAVI). Remaining districts
supported by a separate PBF/HSS
project of the BTC.
140 zones in the (old) provinces of Katanga,
Équateur, Bandundu and Maniema
2015-2017 pilot in 4 districts
2017-2019: extended to 19 districts (out of 86)
2019-2021: plans to scale up to entire country -
additional 31 districts in 2019 (to 50 districts),
additional 23 districts in 2020 (73 districts in total),
additional 13 districts in 2021 (86 districts in total)
3 departments, later
extended
Main
implementing
partner
World Bank World Bank World Bank World Bank
Funding (WB) $11 million $226.5 million $35.8 million (2015-2019) $90 million (2013-2018)
PBF design features
Facilities covered Public and private not-for-profit
(PNFP) facilities
Public and private not-for-profit (PNFP) facilities
(agrées)
Public and some private not-for-profit (PNFP)
facilities
Public and private not-for-
profit (PNFP) facilities
Indicators
covered
28 indicators at health centre level and
14 indicators at hospital level
22 indicators at health centre level and 24
indicators at hospital level.
26 indicators at health centre level and 28
indicators at hospital level,
16 indicators at health
facility level, and 5 at
hospital level.
PBF payment
calculation
Fixed payment per output, modified
by a facility quality score
Fixed payment per output, modified by a facility
quality score with an equity bonus element to
compensate for remoteness
Fixed payment per output, modified by a facility quality score
Use of PBF funds Max 50% health workers
Min 50% facility operational costs
Max 50% health workers
Min 50% facility operational costs
Max 50% health workers Min 50% facility
operational costs – excluding drugs
Max 70% HWs - Min 30%
facility operational costs
Verification Quantity: an international agency
Quality: district health management
teams (peers for hospitals)
Community monitoring through
contracted local NGOs.
Quantity: provincial EUPs (purchasing structures
established by the programme)
Quality: health zones
Community monitoring through contracted
local NGOs
External counter-verification by an international
agency
Quantity: an international agency
Quality: district health management teams
Community monitoring through contracted local
NGOs.
Quantity: an international
and two national NGOs
Quality: district health
management teams
Community monitoring
through contracted local
NGOs.
37. 1. The GF’s perspective
Expectations and rationale for GF’s involvement in PBF not always fully explicit but included
different elements such as:
◦ An experimental interest to learn about the model as one approach to PfR, by investing in
it
◦ Taking advantage of the existence of well-development models as a possible vehicle for
HSS
◦ Seeing the PBF programmes as an approach to donor harmonisation: the Global Fund was
not the only partner ‘buying in’ – a number of other international agencies have also
invested in different settings, such as GAVI, USAID and UN agencies.
38. Benin DRC Cote d’Ivoire Haiti
Global Fund’s involvement
Period 2015-2017 2018 2017-2019 2015-2017
Funding $34m stand-alone HSS grant (Round 9) $5.4 million USD (of the
initially pledged 10 million)
$3 million (NFM1 & NFM2 malaria grant)
to cover 3 districts
$1.7 million originally budgeted, less
than $600,000 spent (HIV/TB grant) to
cover 50 facilities
Cash flow and
partnership set
up
Through WB’s project implementation unit.
Separate bank accounts for WB and GF-
supported districts/activities
Trust fund to the WB To National Malaria Control Programme,
GF’s PIU and then to the PBF unit of the
MoH
Separate PIU for GF and WB
To PSI and then to the WB’s Project
Management Unit in charge of PBF
(separate bank account)
Partnership with
WB
• GF’s involvement in design: varied across the settings, but the PBF model was essentially determined by the World Bank in negotiation with national partners, with
the Global Fund contributing to expansion of the model to new areas of the country for the agreed indicator package as a whole
• Generally constructive, with a recognition of the expertise developed by the World Bank in PBF, but with some frustration on the Global Fund side about the lack
of detailed information sharing and substantive involvement in management of the programme and oversight of results
Other GF
partners
PR: WB’s PBF project implementation unit No PR PR: national malaria programme PR: international NGO (PSI)
• Limited role for PRs, CCMs and LFAs to play in relation to PBF programmes, given that the latter already have clearly defined approaches and internal structures
• The role of a distinct PR when funds are being directly transferred to a PBF management unit needs consideration to ensure value added beyond fund transfers
Other partners
in PBF
programme
WB, GF, GAVI
(BTC)
WB. GF, GAVI, USAID,
(UNICEF, UNFPA)
WB, GF, (UNICEF, USAID) WB, GF (Canada, USAID)
39. Operational challenges to GF’s involvement
Lack of fit between the PBF and GF’s budget categories
◦ PBF budgets: transfers to facilities, management and verification costs.
◦ Expenditures depend on outputs prediction complex (e.g. in Cote d’Ivoire GF’s budget was
expended before end support)
◦ GF is more used to commodities-based support (easier to predict)
Difference in reporting indicators and performance frameworks
◦ In Haiti, indicators in the GF’s PF related to the accuracy and consistency of reporting
◦ In Benin, the GF’s PF included outcome indicators which were impossible to monitor every 6 months
Lack of specific PBF expertise
◦ In these cases, the GF had no direct design and implementation role, but was relying on WB – there are
advantages in the division of tasks but also some frustrations
40. 2. PBF integration and sustainability
Integration with overall PHC financing
◦ Despite PBF, there are system constraints on fund management and autonomy at facility level
◦ Benin: multiple funding streams with different requirements and complex PBF procedures
underspent on PBF
◦ Cote d’Ivoire: despite efforts, limited financial autonomy at facility level, with facilities not seen as
autonomous units (e.g., user fees not retained and banking done at district level) in the context of a
wider political economy of decentralisation.
Human resources for health
◦ Role in retaining and motivating staff especially in underfunded systems. However, risk of adding to the
proliferation of health worker incentive payment (DRC)
Health Information Systems
◦ In all case studies, PBF reporting systems remain separate from HMIS. HMIS would have a more
important role if ‘risk-based verification’ is introduced.
41. PBF integration and sustainability (2)
As found in other studies, integration with HS and tailoring/adaptation to context
(including local political economies and health system challenges and features) is
important to the question of sustainability of PBF
In the case study settings, PBF sustainability varied – two examples:
◦ Benin: PBF was discontinued nation-wide in due to the impossibility of harmonising different
approaches (WB/GF/GAVI – BTC) and lack of ownership from the MoH
◦ Cote d’Ivoire: WB PBF project (SPARK-health) to align with ongoing health insurance reform
and complement purchasing mechanisms potential for integration and sustainability
42. 3. PBF as a donor coordination mechanism
PBF as an approach to donor harmonisation is one of the reasons for GF’s engagement in PBF,
along with other partners
Benin DRC Cote d’Ivoire Haiti
Partners in
PBF
programme
WB, GF, GAVI
(BTC implementing a
different PBF model)
WB. GF, GAVI, USAID, UNICEF,
UNFPA
WB, GF, UNICEF, USAID WB, GF, Canada, USAID (with
different model/implem
arrangements)
Division of
tasks
Geographical division Geographical division +
support to specific areas
Geographical division + support to
specific areas
Geographical division (target
specific facilities)
Financing
flows
All partners funding the PBF
PIU (set up by the WB and
within/on the side of the
MoH). However, separate
bank accounts for each
partner
• Trust funds with the WB
for GF, GAVI, USAID
• Complementary (in-kind)
contributions from UNICEF
and UNFPA
• GF funding via National Malaria
Control Programme -> GF’s PIU
-> WB/PBF PIU
• Complementary (in-kind)
contributions for UNICEF and
USAID
• GF funding via PSI and
WB PBF PIU (separate
bank account)
• Separate funding for
others
43. PBF as a donor coordination mechanism (2)
How did that work in practice?
◦ Overall, there was no real pooling of funds in a joint basket in any of the case studies.
Benin: coordination worked well for WB, GAVI, GF adopting the same PBF model/design and
implementation mechanisms – but it proved difficult to harmonise with that of the BTC
DRC: frustrations around the time-consuming creation and management of the Trust Fund, so the
experience was short lived. WB’s coordination with other partners (partially) continues.
Cote d’Ivoire & Haiti: partnership was less close (involving separate PIUs and cash flows) and
reverted to a ‘division of tasks’ with WB and GF coordinating their activities and providing
separate, but complementary support
◦ Haiti: ‘joint investment’ modality as per WB-GF Framework Agreement
45. PBF vs DFF?
The review highlights the shared health system requirements of PBF and DFF, their potential
complementarities, and their shared potential to strengthen health systems and outcomes when
appropriately deployed.
The evidence base in relation to effects is more developed for PBF.
In studies comparing PBF with interventions using less conditional direct cash financing, neither
model comes out as consistently superior in general.
◦ When adjusted for additional resources, PBF performs somewhat better than input-based controls for
some quality and autonomy measures
◦ But less well for utilisation
◦ And with no difference in general on health outcomes, despite slightly higher expenditure
46. Shared requirements
PBF is sometimes portrayed as complex and DFF simple but both require considerable groundwork in
terms of:
◦ design and implementation of system strengthening components (such as reinforcing management skills at
facility level, access to banking, improved supervision and health information systems);
◦ a broader supportive environment in which there is a willingness to decentralize and adequate funding;
◦ programme design and implementation components, such as:
◦ estimating funding amounts needed by facilities, taking into account the degree of subsidies from other sources and the funds
which are required at facility level;
◦ determining reporting, verification and performance review approaches;
◦ agreeing, monitoring and enforcing policies on charges to users;
◦ determining and enforcing any rules on staff benefits from the funds, and on how funds can be used more generally.
47. Both are/can be HSS
PBF/DFF should be seen as health system strengthening interventions (not just health financing
interventions), as they impact on all system areas and should in principle be coherent with
arrangements in them
◦ e.g. health worker remuneration, drug supply systems, governance, public financial management (PFM)
systems, health information systems, service packages, infrastructure quality and distribution, and
measures to address community access barriers
PBF/DFF mechanisms of change are also more complex than the labels imply: the labels focus
on finance, and resources are indeed important to effects observed. However, there are many
other components which are important
◦ including feedback on effort, signaling of priorities, support for planning, more focus on data and results
and greater autonomy for facility managers among others
There are differences between PBF and DFF: verification/risk approach different, so depends on
the context needs (and degrees of trust)
48. Rationale for GF investment
◦ Neither approach is likely to improve ‘operational efficiency’ of the Global Fund, in that they are relatively
complex to establish, monitor and assess;
◦ In terms of increasing disbursement, DFF is more promising, in that it has fewer controls that limit
expenditure; overall costs are also easier to predict and control;
◦ In relation to reducing financial barriers for users, both programmes could potentially reduce these, but this
component needs more explicit attention and enforcement as results have been disappointing to date
◦ More generally, as a system strengthening intervention, both have promise if designed with good fit to the
context and its blockages.
◦ Both (independently or complementarily) can provide the small but essential flexible resources which are needed at
facility level to support integrated care packages
◦ Both can provide a mechanism for donor harmonization.
◦ PBF benefits from a longer period of intense experimentation and documentation of its model
◦ DFF benefits from a more integrated approach, with lower costs and potentially more sustainability
◦ Both require complementary interventions at community level given that they only focus on facility-based services
Editor's Notes
Don’t need to present all 3 sections in the two webinars. We can choose which are most adapted (or even drop one altogether for both webinars)
(1) and possibly even (2) can be taken out for Accelerator presentation – what do you think?
Sophie, are you covering this already?
Difference in reporting indicators and performance frameworks
PBF generates reports on number of services delivered and quality scores for facilities, which do not match the indicator set of the Global Fund (usually higher level/health system indicators
Lack of specific PBF expertise
Important to engage beyond the technical details of the programme to understand how it fits and interact with the wider (health) system
Understanding the underlying provider payment mechanisms to health centres and the intersection of the PBF mechanisms with the overall financing of PHC is important to the question of sustainability. PBF aims to increase the resources available to manage front-line services and the freedom to deploy them appropriately, but system constraints continue to hamper that in the case study countries.
Benin: underspent staff are concerned about being held accountable if funds are wrongly used. The PBF manual has complex requirements, which fall on top of the ‘regular’ national ones. Some work-arounds have been found, such as using the funds to purchase of drugs which can then be sold to provide funds to the facility.
Indeed, the Global Fund was not the only partner ‘buying in’ – a number of other international agencies have also invested in different settings
DRC: support to specific areas – i.e., UNICEF WASH, UNFPA family planning, …
DRC: UNICEF=WASH, USAID=training
Not easy to tease out lessons from the case studies